Vaccine for new COVID disease in 2025?
$5,680 Vol.
Rules
On February 21, a bat coronavirus that has the capacity to spread to humans, known as HKU5-CoV-2, was reportedly discovered (See: https://www.aa.com.tr/en/asia-pacific/china-discovers-new-bat-coronavirus-that-poses-risk-of-animal-to-human-transmission/3489013)
This market will resolve to "Yes" if any vaccine intended for humans and inoculating against HKU5-CoV-2 receives full FDA approval between February 20, and December 31, 2025, 11:59 PM ET. Otherwise, this market will resolve to "No".
The primary resolution source for this market will be information from the FDA, including their official list of approved vaccines (https://www.fda.gov/vaccines-blood-biologics/vaccines/vaccines-licensed-use-united-states).
This market will resolve to "Yes" if any vaccine intended for humans and inoculating against HKU5-CoV-2 receives full FDA approval between February 20, and December 31, 2025, 11:59 PM ET. Otherwise, this market will resolve to "No".
The primary resolution source for this market will be information from the FDA, including their official list of approved vaccines (https://www.fda.gov/vaccines-blood-biologics/vaccines/vaccines-licensed-use-united-states).
Volume
$5,680
End Date
Dec 31, 2025
Resolver
0x6A9D222616...$5,680 Vol.
Vaccine for new COVID disease in 2025?
About
On February 21, a bat coronavirus that has the capacity to spread to humans, known as HKU5-CoV-2, was reportedly discovered (See: https://www.aa.com.tr/en/asia-pacific/china-discovers-new-bat-coronavirus-that-poses-risk-of-animal-to-human-transmission/3489013)
This market will resolve to "Yes" if any vaccine intended for humans and inoculating against HKU5-CoV-2 receives full FDA approval between February 20, and December 31, 2025, 11:59 PM ET. Otherwise, this market will resolve to "No".
The primary resolution source for this market will be information from the FDA, including their official list of approved vaccines (https://www.fda.gov/vaccines-blood-biologics/vaccines/vaccines-licensed-use-united-states).
This market will resolve to "Yes" if any vaccine intended for humans and inoculating against HKU5-CoV-2 receives full FDA approval between February 20, and December 31, 2025, 11:59 PM ET. Otherwise, this market will resolve to "No".
The primary resolution source for this market will be information from the FDA, including their official list of approved vaccines (https://www.fda.gov/vaccines-blood-biologics/vaccines/vaccines-licensed-use-united-states).
Volume
$5,680
End Date
Dec 31, 2025
Resolver
0x6A9D222616...
Beware of external links.
Beware of external links.